CT pulmonary angiography had a sensitivity of detecting CTEPH of 51% compared with a >96% sensitivity of ventilation/perfusion scan. 95 A normal ventilation/perfusion scan virtually excludes CTEPH, ...

Quantitative CT is becoming increasingly common for the characterisation of lung disease; however, its added potential as a clinical tool for predicting severe exacerbations remains understudied. We ...

A research team led by Prof. LI Hai from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences, has ...

Pulmonary hypertension (PH) is a progressive disease with a poor prognosis. Identifying chronic thromboembolic pulmonary disease as a cause of PH has major clinical implications as these patients ...

Objective Earlier detection of pulmonary arterial hypertension (PAH), a leading cause of death in systemic sclerosis (SSc), facilitates earlier treatment. The objective of this study was to develop ...

Pulmonary nodule quantification is essential in forecasting and diagnosing potential malignant nodules, providing critical information for early intervention and treatment planning. However, most ...

Pulmonary hypertension (PH) is a life-threatening condition and is associated with patients with idiopathic inflammatory myopathy (IIM). Although interstitial lung disease (ILD) is frequently found ...

Context Right heart catheterisation is the gold standard for the diagnosis of pulmonary hypertension. However, echocardiography is frequently used to screen for this disease and monitor progression ...

There is increased risk for pulmonary hypertension in patients with both atrial fibrillation and incident venous thromboembolism.

Persistent pulmonary hypertension of the newborn (PPHN) is the most common neonatal form and mostly reversible after a few days with improvement of the underlying pulmonary condition. When pulmonary ...

Lung cancer becomes one of the diseases with a high mortality rate. The identification of lung nodules as a representation of lung cancer becomes a very important part. One method of identifying lung ...

Merck said that a phase-three study of its pulmonary arterial hypertension treatment met its primary endpoints. On Monday, the pharmaceutical company said it has received positive topline results ...